Free Newsletter
The 15 most promising biotech companies
Every year our sister publication FierceBiotech publishes the Fierce 15, a list of the most promising private biotech companies. This year's report is made up of drug developers who have vision, good science and solid management that have helped them not only suvive but excel in the face of economic challenges. These biotechs boast ground-breaking technologies that are redefining the biotech industry amidst adverse market conditions. Some of the winning innovations include a potentially new generation of anti-bacterials, advancements in oncology treatments, and cutting-edge developments in the stem cell field.
Click here to see the 2009 Fierce 15 winners. Report
Comments
Post new comment
Paid Research Reports
- The Specialty Pharma Market Outlook: Key players, new company growth models and emerging opportunities
- Investigating Clinical Trial Costs: Comparative analysis of trial cost components in key geographies
- Clinical Trial Recruitment Strategies: Optimizing patient recruitment and retention in late stage clinical trials
- Pipeline Insight: Therapeutic Cancer Vaccines - Prospect of first approval set to reinvigorate interest from major companies
- Stakeholder Opinions: Vaccines in Emerging Markets (Asia) - Opportunities in China, India, South Korea and Taiwan
- Big Pharma Performance Before, During and Beyond the Global Recession
SHARE
WITH: